Management of the Rh-sensitized patient. A 3 year experience with amniocentesis and intrauterine transfusion.
D000653:Amniotic Fluid / Q000032:analysis*; D001787:Blood Group Incompatibility; D001805:Blood Transfusion, Intrauterine / Q000009:adverse effects; D004899:Erythroblastosis, Fetal; D005260:Female; D005313:Fetal Death / Q000209:etiology; D006400:Hematocrit; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000209:etiology; D008722:Methods; D010298:Parity; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy*; D011295:Prenatal Care; D044469:Racial Groups; D012204:Rh-Hr Blood-Group System
D012204:Rh-Hr Blood-Group System